Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
reslizumab (cinqair) (1 trial)
Sinusitis (Phase 3)
Trials (1 total)
Trial APIs (1 total)